SecSonar.com

Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Kiora Pharmaceuticals, Inc. (KPRX) is a Biotechnology company based in US with a market capitalization of $11.9M. Free cash flow was negative at -$10.1M. This page tracks KPRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 12 employees · IPO Feb 13, 2015

Valuation

Valuation & price

$2.50 · as of May 17, 2026 · -21.4% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.74

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.15$2.48$1.80Jul 25Dec 25Jun 26Jul 7, 25$2.81Jul 9, 25$2.97Jul 11, 25$3.00Jul 15, 25$3.00Jul 17, 25$3.15Jul 21, 25$3.09Jul 23, 25$3.11Jul 25, 25$2.99Jul 29, 25$2.74Jul 31, 25$2.60Aug 4, 25$2.54Aug 6, 25$2.43Aug 8, 25$2.36Aug 12, 25$2.50Aug 14, 25$2.53Aug 18, 25$2.88Aug 20, 25$2.65Aug 22, 25$2.73Aug 27, 25$2.86Aug 29, 25$2.78Sep 3, 25$2.80Sep 5, 25$2.68Sep 9, 25$2.63Sep 11, 25$2.70Sep 15, 25$2.61Sep 17, 25$2.65Sep 19, 25$2.53Sep 23, 25$2.54Sep 25, 25$2.57Sep 29, 25$2.63Oct 1, 25$2.83Oct 3, 25$2.75Oct 7, 25$2.73Oct 9, 25$2.82Oct 13, 25$2.72Oct 16, 25$2.70Oct 20, 25$2.55Oct 22, 25$2.26Oct 24, 25$2.56Oct 28, 25$2.46Oct 30, 25$2.55Nov 3, 25$2.47Nov 5, 25$2.34Nov 7, 25$2.33Nov 11, 25$2.29Nov 13, 25$2.19Nov 17, 25$2.09Nov 19, 25$1.92Nov 21, 25$1.87Nov 25, 25$1.80Nov 28, 25$1.98Dec 2, 25$1.89Dec 5, 25$2.03Dec 9, 25$2.06Dec 11, 25$2.14Dec 15, 25$2.06Dec 17, 25$2.05Dec 19, 25$2.16Dec 23, 25$2.12Dec 26, 25$1.97Dec 30, 25$1.94Jan 2, 26$2.02Jan 6, 26$2.12Jan 8, 26$2.19Jan 12, 26$2.17Jan 14, 26$2.22Jan 16, 26$2.16Jan 21, 26$2.18Jan 23, 26$2.12Jan 28, 26$2.14Jan 30, 26$2.40Feb 3, 26$2.26Feb 5, 26$2.12Feb 9, 26$2.22Feb 11, 26$2.14Feb 13, 26$2.08Feb 18, 26$2.09Feb 20, 26$1.98Feb 24, 26$2.01Feb 26, 26$2.10Mar 2, 26$2.06Mar 4, 26$2.04Mar 6, 26$1.98Mar 10, 26$2.18Mar 12, 26$2.15Mar 16, 26$2.09Mar 19, 26$2.03Mar 23, 26$2.04Mar 25, 26$2.04Mar 27, 26$1.88Mar 31, 26$1.93Apr 2, 26$1.94Apr 7, 26$2.16Apr 9, 26$2.48Apr 13, 26$2.44Apr 15, 26$2.54Apr 17, 26$2.52Apr 21, 26$2.45Apr 23, 26$2.40Apr 27, 26$2.32Apr 29, 26$2.35May 1, 26$2.44May 5, 26$2.51May 8, 26$2.45May 12, 26$2.44May 14, 26$2.58May 18, 26$2.51May 20, 26$2.64May 22, 26$2.56May 27, 26$2.79May 29, 26$2.68Jun 2, 26$2.72Jun 4, 26$2.63Jun 8, 26$2.58Jun 10, 26$2.63Jun 12, 26$2.55Jun 16, 26$2.62Jun 18, 26$2.53Jun 23, 26$2.60Jun 29, 26$2.61
$1.8052-week range$3.18
Loading valuation history…

Fundamentals

Key fundamentals

$11.9M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$10.1M

Free cash flow (USD)

-$16.7M

Net debt

Net cash position

7.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$669.3KFY 2017$407.5KFY 2018$1.7MFY 2019$2.7MFY 2020$12.1KFY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$16.0MFY 2025$0.00
$669.3K$0

Free cash flow by year

2016 → 2025

FY 2016$-8.4MFY 2017$-6.5MFY 2018$-11.1MFY 2019$-8.2MFY 2020$-7.3MFY 2021$-10.7MFY 2022$-10.4MFY 2023$-9.6MFY 2024$8.6MFY 2025$-10.1M
-$8.4M-$10.1M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventPreclinical Data AnnouncementJun 18, 2026Filing
  • 8-K eventEquity Incentive Plan AdoptionJun 11, 2026Filing
  • FinancingSecurities RegistrationMay 18, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • 8-K eventSecurities Purchase AgreementApr 7, 2026Filing
  • 8-K eventChief Development Officer ResignationApr 2, 2026Filing

Questions

Frequently asked questions

What is Kiora Pharmaceuticals, Inc.'s market cap?

Kiora Pharmaceuticals, Inc. (KPRX) has a market capitalization of $11.9M.

What is KPRX's P/E ratio?

A meaningful P/E ratio is not available for KPRX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is KPRX's price-to-book (P/B) ratio?

KPRX trades at 0.74 times book value per share.

Are insiders buying KPRX stock?

SEC Form 4 filings show no open-market insider buys at Kiora Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

LEXX

Lexaria Bioscience Corp.

$12.2M

VYNE

VYNE Therapeutics Inc.

$11.4M

AIMD

Ainos, Inc.

$11.4M

OSRH

OSR Holdings, Inc.

$10.8M

HIND

Vyome Holdings, Inc.

$13M

LPCN

Lipocine Inc.

$13.2M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.